W.W. Grainger’s (GWW) PE ratio of 16.3x compares to a sector average of 29.3x. The dividend yield of 3.2% compares to a sector average of 1.6%.
Procter & Gamble’s (PG) PE ratio of 25.1x compares to a sector average of 23.3x. The dividend yield of 3.0% compares to a sector average of 3.8%.
Cardinal Health’s (CAH) PE ratio of 16.0x compares to a sector average of 20.4x. The dividend yield of 2.9% compares to a sector average of 2.0%.
Nucor’s (NUE) PE ratio of 21.8x is pitted against a sector average of 19.4x. The dividend yield of 1.5% is pitted against a sector average of 1.4%.
Franklin Resources (BEN) has recorded consistent growth in dividends since at least March 1982.
This year marks Aflac’s (AFL) 35th successive year of dividend growth. But its operating cash flow has shown a declining trend over the years.
In this series, we’ll be looking at ten dividend aristocrats with low PE ratios. Dividend aristocrats are S&P 500 stocks that have raised their dividend payouts for at least 25 successive years.
Kimberly-Clark’s (KMB) 2016 net sales fell 2.0% due to declines in every segment.
Coca-Cola (KO) recorded a fall of 6.0% in its 2016 net operating revenues due to a decline in its Third Party and Intersegment segments.
Genuine Parts (GPC) recorded a marginal growth in its 2016 net sales, driven by its Automotive and Office Products segments.
Consolidated Edison’s (ED) 2016 operating revenues fell 4.0% due to a decline in every segment; namely, electric, gas, steam, and non-utility.
Emersion Electric’s (EMR) 2016 net sales fell 11.0% due to a fall in every segment.
AbbVie (ABBV) recorded a 12.0% rise in net revenue for 2016, mainly driven by Humira and Imbruvica.
ExxonMobil’s (XOM) story is similar to Chevron’s. The company’s sales and other operating revenue for 2016 fell 16.0%.
Chevron’s (CVX) total sales and other operating revenues for 2016 fell 15.0% due to volatility in commodity prices.
Target’s (TGT) sales for 2016 fell 6.0% due to lower comparable store sales and weak store traffic.
AT&T (T) has managed to record growth in its 2016 revenues, mainly driven by its Entertainment Group and International segments.
The S&P 500 Dividend Aristocrat Index is made up of 51 S&P 500 (SPY) (SPX-INDEX) companies that have increased their dividends for 25 successive years.
Johnson & Johnson’s (JNJ) EPS (earnings per share) for the first half of 2017 fell 0.70%, driven by higher selling, marketing, and administrative and R&D expenses.
Pharmaceutical ETFs are securities designed for investors who do not have the capacity to hold many stocks but are interested in diversification of their investments within the pharmaceutical sector. Besides…